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What is the significance of the present work? Huang
et al. were able to use the relatively noninvasive tech-
nique of rTMS to obtain direction-specific LTP and LTD-
like excitability aftereffects in the human motor cortex.
Toward Establishing a Both quantitatively and qualitatively, these effects far
outweigh the effects seen to date using other rTMSTherapeutic Window for rTMS
protocols. From the perspective of those interested inby Theta Burst Stimulation
the mechanisms of LTP/LTD, these effects were ob-
tained bymimicking the theta burst stimulation protocol
widely used for the induction of LTP/LTD (Larson et al.,
1986), and in fact, a similar dissociation of facilitationIn this issueofNeuron, Huang et al. show that a version
and inhibition for different lengths and patterns of trainsof the classic theta burst stimulation protocol used to
has been observed in animal studies.induce LTP/LTD in brain slices can be adapted to a
rTMS exerts its effects in the human brain basicallytranscranial magnetic stimulation (TMS) protocol to
by repetitive electrical brain stimulation. It may mimicrapidly produce long lasting (up to an hour), reversible
any LTP or LTD stimulation sequence and is at presenteffects on motor cortex physiology and behavior.
only technically limited by a maximum repetition rate ofThese results may have important implications for the
about 100 Hz and the magnetic field amplitude of aboutdevelopment of clinical applications of rTMS in the
1 to 2 Tesla that is available with modern stimulators.treatment of depression, epilepsy, Parkinson’s, and
In comparison to the LTP/LTD literature, a major disad-other diseases.
vantage of TMS as a mechanism for electrical stimula-
tion of the brain is the poor spatial resolution. Some
While there is a vast literature of animal experiments
have even compared the effect of TMS on the brain
exploring the mechanisms of long-term plasticity, very as being the equivalent of a lightening bolt hitting a
little is know about how these phenomena apply to the television set. Although the spatial precision can be
human brain. Repetive transcranial magnetic stimula- somewhat increased by adapting the configuration of
tion (rTMS), a noninvasive means of magnetically stimu- coils, the induced current flow affects at least several
lating the brain through the intact scalp, has been put cubic centimeters of brain tissue and therefore is cer-
forward as a tool for probing this issue in humans. While tainly far from the single or few neurons that are affected
some evidence for plasticity and changes in function in LTP experiments that use electrical stimulation in
extending beyond the immediate stimulation period animal slice preparations. Although spatial precision is
have been observed, these effects have typically been clearly an issue, it may be possible to achieve some
small, variable, and short term. Clinically, rTMS has been selectivity in human experiments by pairing associative
proposed asa potential therapy for a variety of neurolog- stimulation using TMS with precisely timed somatosen-
ical and psychiatric diseases. But again, here the results sory stimuli. Experiments using such protocols have
have also been disappointing, and overall, progress in also demonstrated impressive LTP/LTD-like aftereffects
the application of rTMShas been hampered by concerns (Wolters et al., 2003).
over safety, which for obvious reasons limit human stud- The rTMS protocols that have been used so far and
ies to lower frequencies than have typically been used that were developed initially in Mark Hallett’s lab at the
in animal studies. NIH relied on the earliest LTP and LTD protocols, using
The goal of the study by Huang et al. (2005 [this issue regular stimulation frequencies: higher (5 Hz) for exci-
of Neuron]) was to test whether application of a theta tation or lower (1Hz) for inhibition. Apart from relatively
burst paradigm (TBS)—low-intensity bursts of rTMA at modest aftereffects, most experiments suffered from
50Hz—could produce evidence of plasticity in themotor rather high interindividual variability. Also, recent experi-
cortex. Three different patterns of TBS (continuous, in- ments on cortical preconditioning challenge the use of
termittent, and intermediate TBS) were applied to the these sometimes ambiguous regular stimulation fre-
primarymotor cortex of subjects. The readouts for these quencies. For example, stimulating themotor cortex first
by a high rTMS stimulation frequency (Iyer et al., 2003)experiments were EMG responses (motor evoked po-
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significantly enhanced the inhibitory, succeeding 1 Hz a number of limitations that prevent this. A recently pub-
lished animal study showed an amelioration of parkinso-rTMS aftereffect of a second rTMS series. This result
was enhanced by using transcranial direct current stim- nian symptoms after 30 min of 110 Hz subthreshold
direct electrical motor cortex stimulation, but the effectulation (tDCS). With inhibitory cathodal tDCS precondi-
tioning, the excitability normally induced by succeeding only lasted about 1 min after the end of stimulation
(Drouot et al., 2004). One potential complication of the1 Hz or 5 Hz rTMS protocols was reversed; inhibitory
rTMS became excitatory and vice versa (Siebner et al., application of conventional excitatory stimulation proto-
cols is seizure induction. There have been reports of2004). It is worth noting that in some cases—for exam-
ple, in migraine patients where it has been proposed seizures in response to rTMS, and as a consequence,
safety criteria prescribing the upper frequency and in-that a hyperexcitable cortex might be an underlying
cause—homeostatic plasticity could contribute to the tensity limits have been developed (Wassermann, 1998).
By making clever use of lower levels of stimulation tovariability in conventional rTMS study results. Given
these problems plaguing the earlier experiments in this achieve their effects, the paper by Huang et al. lays the
foundation for a new era of rTMS stimulation, with aarea, a potentially more reliable and stable protocol,
such as the theta burst stimulation paradigm outlined distinctly greater likelihood of a larger therapeutic effect
and with a possibly smaller risk of seizure induction.here, would be awelcome advance in terms of providing
a greater specificity and efficacy for rTMS. Other physical safety concerns, such as tissue heating,
have already lost importance with the growing body ofOne might ask what it is about this particular protocol
that makes it more efficacious? At first glance, TBS data on the long-term safety of deep brain stimulation
in, for example, Parkinson’s disease patients. Clearly,sequences suffer from the same problems of inducing
amixture of facilitatory and inhibitory effects on synaptic physiological safety issues specific to the protocol will
need to be further evaluated, but the present data pro-transmission. However, the authors found a clever way
to convert this apparent disadvantage into an advantage vide a new option for possibly dissociating the risk of
seizure induction from other risk factors, such as induc-by using the temporal dissociation by which TBS in-
duces excitation and inhibition (see Figure 2 in Huang ing irreversible maladaptive plastic changes. For the
large group of therapy-resistant epilepsy patients, cTBSet al., 2005). A curious aspect of the observed effects
is that, while the excitatory effect induced here builds up as a method for reducing epilepsy (Tergau et al., 1999)
would be a major advance, but clearly a worsening ofwithin 1 s, with a rapid decline, the inhibitorymechanism
builds up with a latency of several seconds. Thus, in their seizure load must be avoided. A cautious explora-
tion of safety limits by always ensuring the reversibilitythe inhibitory “continuous” cTBS, an initial (seemingly
paradoxical) facilitation cannot be avoided in the first of all aftereffects, in normal subjects and in patients,
will continue to be the best means of advancing thissecond, but after some seconds, inhibition overrides
facilitation. In contrast, in order to obtain excitation, this field in the future, as in the past.
Is there more that can be done to improve efficacylater inhibition needs to be overcome. Thus, the iTBS
mode only uses the early excitatory effect in the very while simultaneously reducing safety concerns? A com-
bination of theta burst with neuropharmacology seemsfirst 2 s. After 2 s, stimulation is interrupted for 8 s, which
prevents inhibition from building up. This, of course, to be the best option, not only for unravelling the basic
physiological parameters and mechanism of plasticityrequires a kind of “excitatorymemory” lasting for at least
10 s, which after some cycles can be further boosted in in humans, but also for increasing the specificity and
efficacyof rTMS. Todate, relevant pharmacological datasuch a way that an excitation can increase and last for
up to an hour. What mechanisms account for these have been collected mainly through tDCS. Although
tDCS is thought to induce LTP/LTD-like effects by aeffects? Most likely, the underlying mechanisms will in-
volve many of the basic elementary mechanisms de- different mechanism (altering the neuronal membrane
potential; Nitsche et al., 2003), it shares some features,scribed previously in the LTP/LTD literature.
From a clinical and therapeutic perspective, a major such as size, specificity, duration and proportionality
between stimulation duration and duration of afteref-issue related to the use of TMS protocols such as these
is safety—in particular, the risk of seizure induction has fects, with the results shown by Huang et al. tDCS after-
effects are N-methyl-D-aspartate (NMDA) receptor de-beenamajor concern. Adecade ago, earlywork from the
labs of Robert Belmarker, Mark George, Alvaro Pascual- pendent and are completely abolished by the NMDA
receptor antagonist dextrometorphane (Nitsche et al.,Leone, and others raised the possibility and hope that
the rTMS protocols might become alternatives to elec- 2003). tDCS-induced excitability increases of about 1–2
hr can be extended by stimulation in the presence oftroconvulsive therapy in treating therapy-resistantmajor
depression. Therewas evidence to suggest that, at least drugs such as amphetamine or the partial NMDA agonist
d-cycloserine (Nitsche et al., 2004) to an almost 24 hrin some patients, excitatory stimulation of the left dorso-
lateral prefrontal cortex (DLPF) could alleviate some range. It remains to be seen whether this also holds for
TBS or whether there is the possibility of prolonging thesymptoms or improve depression, presumedly by re-
versing DLPF hypoactivity. However, until now the effi- aftereffects pharmacologically. It is unclear whether one
might be able to selectively suppress excitatory afteref-cacy of such treatments has been too variable to allow
the introduction of rTMS as a standard therapy. One fects associated with the rTMS protocol, for instance,
with the sodium channel blocker carbamazepine or thereason for this may have been the relatively short dura-
tion of aftereffects that usually lasted less than 30 min. calcium antagonist flunarizine, such as has been shown
for tDCS (Nitsche et al., 2003). If similar effects alsoOne might ask why this problem could not be overcome
by further increasing the frequency and/or intensity of apply to theta burst stimulation, it might be possible (for
instance, in epilepsy patients) to treat with carbamazep-rTMS in the treatment of depression? In fact, there are
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ine or flunarizine to further reduce the risk of unwanted brain, focusing here on cortical projection neurons.
We discuss these findings and the implications of thisexcitatory effects.
In sum, it seems that future rTMS protocols will most development for both systems and molecular neuro-
science.likely need distinctly fewer stimuli and less intensity—
and hence less energy—to produce even longer and
much clearer inhibitory and facilitatory aftereffects, but Advances in technology clearly drive discovery in sci-
there is still much work to be done. Clearly, it will need ence, but often there is a lag between development of
to be investigated whether combining rTMS with other the technology and optimization of its implementation.
methods will in fact improve its therapeutic efficacy. This year marks the tenth anniversary of the birth of
Also, for areas outside the primary motor cortex, other the cDNA microarray (Schena et al., 1995), which was
methods for the quantification of TBS effects, beyond closely followed by the development of the oligonucleo-
measuring motor evoked potentials, will be needed. tide arrays for gene expression analysis (Lockhart et al.,
rTMS in combination with functional fMRI may be one 1996). Thus, it is an opportune time to reflect on what
solution (Bestmann et al., 2004). microarrays have contributed to our understanding of
the nervous system.
Initially, the greatest successes withmicroarrayswereWalter Paulus
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such as yeast or T cells, and they were rapidly appliedUniversity of Goettingen
to the study of cancer and metabolic regulation (DeRisiD-37075 Goettingen
et al., 1996; Lockhart et al., 1996; Shalon et al., 1996).Germany
Many neuroscientistswere initially skeptical of the appli-
Selected Reading cation of these powerful methods to a complex tissue
such as the brain. Nonetheless, many studies pro-
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Progress in Realizing proportion of cell types (such as a loss of neurons or
gliosis), change in expression in all cells, change in ex-the Promise of Microarrays
pression in a fraction of cells, invasion of a new cellin Systems Neurobiology
type (such as inflammatory cells), or combinations of all
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It is in this context that work reported in this issue of
Neuron by Arlotta, Molyneaux, and colleagues presentsThe power of microarrays in neuroscience has been
challenged by the cellular heterogeneity and complex- an elegant solution to the problem of CNS heterogeneity
by applying a combination of classic anatomical tech-ity of the central nervous system. In this issue of Neu-
ron, Arlotta, Molyneaux, and colleagues have devel- niques and flowcytometry to isolate a specific subpopu-
lation of neurons from the cerebral cortex for microarrayoped a technique combining retrograde labeling, flow
cytometry, and microarrays to purify and molecularly analysis: developing corticospinal motor neurons (CSMN)
(Arlotta et al., 2005). It is important to realize that, rathercharacterize a specific population of neurons from the
